Mail

Canada markets closed

S&P/TSX
21,708.44
+52.39(+0.24%)
S&P 500
5,011.12
-11.09(-0.22%)
DOW
37,775.38
+22.07(+0.06%)
CAD/USD
0.7264
-0.0000(-0.00%)
CRUDE OIL
82.60
-0.09(-0.11%)
Bitcoin CAD
87,353.52
+2,933.64(+3.48%)

MARKETS LIVE BLOG

STOCKS WOBBLE WITH NETFLIX EARNINGS ON DECK

Gas prices: Why one U.S. region will see 'stiff increases' this week

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD

Add to watchlist

1.4300

-0.0100

(-0.69%)

At close: 03:59PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	108.60M
Enterprise Value	74.12M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	3.94
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	-2.22

Trading Information

Stock Price History

Beta (5Y Monthly)	1.46
52-Week Change ³	-10.00%
S&P500 52-Week Change ³	21.61%
52 Week High ³	4.4900
52 Week Low ³	1.2000
50-Day Moving Average ³	1.4348
200-Day Moving Average ³	2.2561

Share Statistics

Avg Vol (3 month) ³	84.26k
Avg Vol (10 day) ³	122.58k
Shares Outstanding ⁵	75.42M
Implied Shares Outstanding ⁶	75.42M
Float ⁸	66.96M
% Held by Insiders ¹	6.16%
% Held by Institutions ¹	6.88%
Shares Short (Mar 28, 2024) ⁴	371.88k
Short Ratio (Mar 28, 2024) ⁴	4.88
Short % of Float (Mar 28, 2024) ⁴	0.53%
Short % of Shares Outstanding (Mar 28, 2024) ⁴	0.49%
Shares Short (prior month Feb 29, 2024) ⁴	303.73k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	May 25, 2018
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	105:1000
Last Split Date ³	May 25, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2023

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-55.47%
Return on Equity (ttm)	-102.66%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-33.71M
Net Income Avi to Common (ttm)	-27.75M
Diluted EPS (ttm)	-0.4100
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	34.91M
Total Cash Per Share (mrq)	0.46
Total Debt (mrq)	423k
Total Debt/Equity (mrq)	1.54%
Current Ratio (mrq)	9.01
Book Value Per Share (mrq)	0.37

Cash Flow Statement

Operating Cash Flow (ttm)	-28.45M
Levered Free Cash Flow (ttm)	-18M